CTX320

Welcome to the Brand page for “CTX320”, which is offered here for Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease; gene therapy products, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease;ctx three two zero; ctx three hundred twenty;gene editing, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, pharmaceutical research and development;.

Its status is currently believed to be active. Its class is unavailable. “CTX320” is believed to be currently owned by “CRISPR Therapeutics AG”.


Owner:
CRISPR THERAPEUTICS AG
Owner Details
Description:
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease; gene therapy products, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease;CTX THREE TWO ZERO; CTX THREE HUNDRED TWENTY;Gene editing, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, pharmaceutical research and development;
Categories: CELLS MEDICAL OR CLINICAL